A large-scale randomized European trial of low-dose CT lung cancer screening yielded a nodule rate of 18% but a cancer detection rate of 0.8%, according to a presentation at the ECR on Friday. A separate study based on the same group underscored the importance of accurately identifying nodule growth rate.
A large-scale randomized European trial of low-dose CT lung cancer screening yielded a nodule rate of 18% but a cancer detection rate of 0.8%, according to a presentation at the ECR on Friday. A separate study based on the same group underscored the importance of accurately identifying nodule growth rate.
The trial was conducted by researchers at three institutions (Groningen, Rotterdam, and Utrecht), with a sample of more than 15,000 participants who were current or former smokers. Participants were randomized into two groups: one was scanned with low-dose 16-slice CT and the other served as a control.
Data from April 2004 through December 2005 were included in the screening study, with a total of 5700 patients screened. A total 1026 patients (18%) were found to have nodules. Of these nodules, 912 were deemed significant and 114 were deemed potentially malignant. Forty-six (0.8%) were found to be lung cancer.
The study is continuing and researchers hope to accumulate a screening population of 8000, said presenter Dr. Y. Wang of Groningen.
Another study involving the same group of participants analyzed nodule growth rates of 453 indeterminate solid nodules over three months to identify which were most likely to grow and proceed to cancer. It found that the chance that fissure- and vessel-attached nodules will grow within three months is less than 8%.
Identifying which lung nodules are most likely to grow has become more important as more nodules are identified on multislice CT scans, said Dr. Donming Xu of Groningen.
Using screening scans of 3881 patients obtained between April 2004 and September 2005, researchers identified 453 indeterminate solid nodules in 331 patients. Twenty percent were fissure-attached, 15% were pleural-based, and 18% were vessel-attached. Eighteen percent of the nodules did not show typical morphological features and 29% were solitary pulmonary nodules. Only 3% of the indeterminate nodules found at baseline had grown more than 25% after three months.
The researchers concluded that focal opacity and solitary pulmonary nodules have the highest possibility of growth, but that pleural-based indeterminate nodules usually do not grow within three months.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.